The abstract establishes that gut microbiota alterations are linked to MS pathology and immune dysfunction, but the precise mechanistic pathways connecting gut dysbiosis to CNS inflammation and neurodegeneration remain unclear. Understanding these mechanisms is critical for developing targeted microbiome-based therapies. Gap type: unexplained_observation Source paper: Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. (None, None, PMID:37979154)
Landscape Summary: What are the specific molecular mechanisms linking gut dysbiosis to MS neurodegeneration and immune dysregulation? is a 0.8 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the specific molecular mechanisms linking gut dysbiosis to MS neurodegeneration and immune dysregulation? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: